Diabetes-associated common genetic variation and its association with GLP-1 concentrations and response to exogenous GLP-1

Diabetes

Volumn 61, Issue 5, 2012, Pages 1082-1089

  Smushkin, Galina ^a   Sathananthan, Matheni ^a   Sathananthan, Airani ^a   Man, Chiara Dalla ^b   Micheletto, Francesco ^b   Zinsmeister, Alan R ^a   Cobelli, Claudio ^b   Vella, Adrian ^a  

^a MAYO CLINIC   (United States)

^b UNIVERSITY OF PADOVA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCAGON LIKE PEPTIDE 1; INSULIN;

ARTICLE; DIABETES MELLITUS; GENE; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOTYPE; HUMAN; HUMAN CELL; HYPERGLYCEMIA; INSULIN RELEASE; KCNQ1 GENE; MAJOR CLINICAL STUDY; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; TCF7L2 GENE; WFS1 GENE;

C-PEPTIDE; DIABETES MELLITUS, TYPE 2; GENETIC PREDISPOSITION TO DISEASE; GENETIC VARIATION; GENOTYPE; GLUCAGON; GLUCAGON-LIKE PEPTIDE 1; GLUCOSE; GLUCOSE CLAMP TECHNIQUE; HUMANS; HYPERGLYCEMIA; INSULIN; INSULIN-SECRETING CELLS; KCNQ1 POTASSIUM CHANNEL; MEMBRANE PROTEINS; TRANSCRIPTION FACTOR 7-LIKE 2 PROTEIN;

EID: 84860588948     PISSN: 00121797     EISSN: 1939327X     Source Type: Journal    
DOI: 10.2337/db11-1732     Document Type: Article

References (27)

1. Drucker DJ. Glucagon-like peptides: regulators of cell proliferation, differentiation, and apoptosis. Mol Endocrinol 2003;17:161-171 (Pubitemid 36183142)
2. Nauck MA, Vardarli I, Deacon CF, Holst JJ, Meier JJ. Secretion of glucagon-like peptide-1 (GLP-1) in type 2 diabetes: what is up, what is down? Diabetologia 2011;54:10-18
3. Fritsche A, Stefan N, Hardt E, Häring H, Stumvoll M. Characterisation of beta-cell dysfunction of impaired glucose tolerance: evidence for impairment of incretin-induced insulin secretion. Diabetologia 2000;43: 852-858 (Pubitemid 30463164)
4. Chen M, Bergman RN, Pacini G, Porte D Jr. Pathogenesis of age-related glucose intolerance in man: insulin resistance and decreased beta-cell function. J Clin Endocrinol Metab 1985;60:13-20 (Pubitemid 15194640)
5. Smushkin G, Vella A. Genetics of type 2 diabetes. Curr Opin Clin Nutr Metab Care 2010;13:471-477
6. Yi F, Brubaker PL, Jin T. TCF-4 mediates cell type-specific regulation of proglucagon gene expression by beta-catenin and glycogen synthase kinase-3beta. J Biol Chem 2005;280:1457-1464
7. Grant SF, Thorleifsson G, Reynisdottir I, et al. Variant of transcription factor 7-like 2 (TCF7L2) gene confers risk of type 2 diabetes. Nat Genet 2006;38:320-323
8. Schäfer SA, Tschritter O, Machicao F, et al. Impaired glucagon-like peptide-1-induced insulin secretion in carriers of transcription factor 7-like 2 (TCF7L2) gene polymorphisms [corrected in: Diabetologia 2008;51:208]. Diabetologia 2007;50:2443-2450 (Pubitemid 350060632)
9. Schäfer SA, Müssig K, Staiger H, et al. A common genetic variant in WFS1 determines impaired glucagon-like peptide-1-induced insulin secretion. Diabetologia 2009;52:1075-1082
10. Müssig K, Staiger H, Machicao F, et al. Association of type 2 diabetes candidate polymorphisms in KCNQ1 with incretin and insulin secretion. Diabetes 2009;58:1715-1720
11. Dahlman I, Eaves IA, Kosoy R, et al. Parameters for reliable results in genetic association studies in common disease. Nat Genet 2002;30:149-150
12. Thomas DC, Clayton DG. Betting odds and genetic associations. J Natl Cancer Inst 2004;96:421-423
13. Dalla Man C, Micheletto F, Sathananthan A, Rizza RA, Vella A, Cobelli C. A model of GLP-1 action on insulin secretion in nondiabetic subjects. Am J Physiol Endocrinol Metab 2010;298:E1115-E1121
14. Sathananthan A, DallaMan C, Zinsmeister AR, et al. A concerted decline in insulin secretion and action occurs across the spectrum of fasting and postchallenge glucose concentrations. Clin Endocrinol (Oxf) 2012;76:212-219
15. Breda E, Cavaghan MK, Toffolo G, Polonsky KS, Cobelli C. Oral glucose tolerance test minimal model indexes of beta-cell function and insulin sensitivity. Diabetes 2001;50:150-158 (Pubitemid 32047994)
16. Eaton RP, Allen RC, Schade DS, Erickson KM, Standefer J. Prehepatic insulin production in man: kinetic analysis using peripheral connecting peptide behavior. J Clin Endocrinol Metab 1980;51:520-528 (Pubitemid 10022835)
17. Lyssenko V, Lupi R, Marchetti P, et al. Mechanisms by which common variants in the TCF7L2 gene increase risk of type 2 diabetes. J Clin Invest 2007;117:2155-2163 (Pubitemid 47219560)
18. Pilgaard K, Jensen CB, Schou JH, et al. The T allele of rs7903146 TCF7L2 is associated with impaired insulinotropic action of incretin hormones, reduced 24 h profiles of plasma insulin and glucagon, and increased hepatic glucose production in young healthy men. Diabetologia 2009;52:1298-1307
19. Shu L, Matveyenko AV, Kerr-Conte J, Cho JH, McIntosh CH, Maedler K. Decreased TCF7L2 protein levels in type 2 diabetes mellitus correlate with downregulation of GIP- and GLP-1 receptors and impaired beta-cell function. Hum Mol Genet 2009;18:2388-2399
20. Elbein SC, Chu WS, Das SK, et al. Transcription factor 7-like 2 polymorphisms and type 2 diabetes, glucose homeostasis traits and gene expression in US participants of European and African descent. Diabetologia 2007;50:1621-1630 (Pubitemid 47036661)
21. Liu PH, Chang YC, Jiang YD, et al. Genetic variants of TCF7L2 are associated with insulin resistance and related metabolic phenotypes in Taiwanese adolescents and Caucasian young adults. J Clin Endocrinol Metab 2009;94:3575-3582
22. Fonseca SG, Ishigaki S, Oslowski CM, et al. Wolfram syndrome 1 gene negatively regulates ER stress signaling in rodent and human cells. J Clin Invest 2010;120:744-755
23. Yusta B, Baggio LL, Estall JL, et al. GLP-1 receptor activation improves beta cell function and survival following induction of endoplasmic reticulum stress. Cell Metab 2006;4:391-406 (Pubitemid 44752565)
24. Vallon V, Grahammer F, Volkl H, et al. KCNQ1-dependent transport in renal and gastrointestinal epithelia. Proc Natl Acad Sci U S A 2005;102: 17864-17869 (Pubitemid 41803588)
25. Gribble FM, Williams L, Simpson AK, Reimann F. A novel glucose-sensing mechanism contributing to glucagon-like peptide-1 secretion from the GLUTag cell line. Diabetes 2003;52:1147-1154 (Pubitemid 36523349)
26. Wang WY, Barratt BJ, Clayton DG, Todd JA. Genome-wide association studies: theoretical and practical concerns. Nat Rev Genet 2005;6:109-118 (Pubitemid 40179533)
27. Vollmer K, Holst JJ, Baller B, et al. Predictors of incretin concentrations in subjects with normal, impaired, and diabetic glucose tolerance. Diabetes 2008;57:678-687